-Data highlights potential of ZL-1503 as a promising treatment for moderate-to-severe atopic dermatitis and other IL-13 and IL-31-driven diseases -Favorable preclinical safety profile, prolonged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback